Clinical trial
A 6-month Randomized, Controlled, Open-label, 2-arm Parallel Group, Multicenter Study to Evaluate the Effect of Switching From Cigarette Smoking to the Use of IQOS in Smokers With Generalized Chronic Periodontitis on the Response to Mechanical Periodontal Treatment and Oral Health Status.
NCT03364751 is registered in ClinicalTrials.gov with Philip Morris Products S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 6-month Randomized, Controlled, Open-label, 2-arm Parallel Group, Multicenter Study to Evaluate the Effect of Switching From Cigarette Smoking to the Use of IQOS in Smokers With Generalized Chronic Periodontitis on the Response to Mechanical Periodontal Treatment and Oral Health Status.
- Lead sponsor
- Philip Morris Products S.A.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 7, 2017
- Completion date
- June 12, 2019
- Enrollment
- 179 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
chronic periodontitis, gingival diseases, periodontal diseases, periodontal pocket, smoking, cigarette, tooth mobility